Skip to content
Screener

Medline, Inc. MDLN Q4 2025 Annual earnings

Reported February 25, 2026 · Before market open

Revenue$7.8BBeat by $274.8M
EPS$0.22Miss by $0.02
Revenue estimate$7.5B
EPS estimate$0.24

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$7.7B
EPS estimate$0.34

Financials

Q4 2025

Income statement

See full
Net income-$7.0M-102%
EPS (diluted)-$0.01—

Balance sheet

See full
Cash & equivalents$1.9B+677%
Total debt$12.9B-23.1%
Total equity$10.7B—
Total assets$38.5B+7.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$33.06B—
Enterprise value$44.05B—
P/E28.5×—

Returns & leverage

See full
Debt / equity1.2×—
Current ratio4.3×+0.9×

Versus estimates

Revenue

Q2 2026$7.7BBeat by $166.2MQ1 2026$7.4BBeat by $189.4M
Q4 2025$7.8BBeat by $274.8M
Q3 2025$7.1B

Diluted EPS

Q2 2026$0.50Beat by $0.15Q1 2026$0.33Beat by $0.03
Q4 2025$0.22Miss by $0.02
Q3 2025$0.31

FAQ

When did Medline, Inc. report Q4 2025 earnings?
Medline, Inc. (MDLN) reported Q4 2025 earnings on February 25, 2026 before market open.
What were Medline, Inc.'s Q4 2025 revenue and EPS?
Medline, Inc. reported revenue of $7.8B and eps of $0.22 for Q4 2025.
Did Medline, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $7.5B by $274.8M. EPS missed the consensus estimate of $0.24 by $0.02.
Where can I find Medline, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0002046386-26-000007) and the 10-K periodic report (0002046386-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.